Covanos, Inc. is a development-stage medical technology company that has developed the C-HEART technology, which uses advanced, proprietary mathematical methods and non-invasive physics-based computational platform solutions for patients.
Subscribe to see Covanos, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Covanos, Inc. is a healthtech company headquartered in United States. Its most recent funding round raised $3M in April 2023. Xcout tracks 9 named people at Covanos, Inc., including Mark P Colonnese (Chief Financial Officer).
3 more named people on record for Covanos, Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Covanos, Inc.'s closest competitors — see the full list of competitors and alternatives →
Cordio Medical develops medical-grade remote monitoring solutions that analyze voice samples through a smartphone application to detect health condition deterioration in near real-time. Its primary product, the Cordio HearO, uses mobile speech analysis to sense fluid accumulation associated with congestive heart failure and alerts healthcare professionals to early clinical decompensation.
One Heart Health develops cost-effective medical technologies, including mobile screening tools and a proprietary app, to enable early diagnosis of congenital heart disease in children living in low-resource regions globally. The organization partners with local programs to facilitate screenings and connect affected children with life-saving cardiac surgeries.
Cardiosense, Inc. is a Chicago-based digital health company that leverages artificial intelligence and multi-sensor devices. It recently completed a $15.1 million Series A financing round to advance its medical technology solutions.
Eko Health is a U.S. digital health company that develops smart stethoscopes and clinical software using artificial intelligence to help detect heart and lung conditions. Its products are intended for healthcare professionals, including primary care clinicians and cardiologists.
Bongiovi Medical & Health Technologies develops advanced audio and software technologies to improve healthcare diagnostics, patient outcomes, and clinical workflows. The company offers medical data devices, AI-powered biological sound analysis, and specialized stethoscopes to assist healthcare professionals in screening, monitoring, and telemedicine applications.
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.